Skip to content

Effectiveness of Pelvic Floor Muscle and Abdominal Training in Women With Stress Urinary Incontinence

Effectiveness of Pelvic Floor Muscle and Abdominal Training in Women With Stress Urinary Incontinence: A Randomized Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03401983
Enrollment
64
Registered
2018-01-17
Start date
2016-09-01
Completion date
2017-03-31
Last updated
2018-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Floor Muscle Weakness, Stress Urinary Incontinence

Keywords

exercise, pelvic floor, stress urinary incontinence

Brief summary

The aim of this study was to investigate the effectiveness of pelvic floor muscle and abdominal training in reproductive-age patients with stress urinary incontinence. This prospective randomized controlled design study included 64 female patients aged 18-49 years with stress urinary incontinence. The patients were divided into 2 groups (32 PFMT Pelvic Floor Muscle Training and 32 PFMT+AT Abdominal Training) by computer-based randomization. The stress urinary incontinence type was assessed by a stress test, and the pelvic floor muscle strength was measured with a home biofeedback device. Voiding functions were assessed by a 3-day voiding diary and uroflowmetric test. The UDI-6 scale was used to assess the urinary symptoms, and the IIQ-7 scale was used to assess the quality of life. The follow-up measurements of both groups were obtained in the 0th, 4th, and 8th weeks.

Detailed description

The aim of this study was to investigate the effectiveness of pelvic floor muscle and abdominal training in reproductive-age patients with stress urinary incontinence. This prospective randomized controlled design study included 64 female patients aged 18-49 years with stress urinary incontinence. The patients were divided into 2 groups (32 PFMT Pelvic Floor Muscle Training and 32 PFMT+AT Abdominal Training) by computer-based randomization. The stress urinary incontinence type was assessed by a stress test, and the pelvic floor muscle strength was measured with a home biofeedback device. Voiding functions were assessed by a 3-day voiding diary and uroflowmetric test. The UDI-6 scale was used to assess the urinary symptoms, and the IIQ-7 scale was used to assess the quality of life. The follow-up measurements of both groups were obtained in the 0th, 4th, and 8th weeks. Participation of 29 patients from each group in the study was determined as sufficient to test the two-way hypothesis, with an effect size of 0.75, with an alpha level of 0.05, and with a power of 80%. However, 32 patients from each group were included as a precaution against possible missing data. These women were randomly divided into the PFMT+AT (n=32) and PFMT (n=32) groups using a computer based randomization scheme. The data were collected from both groups at the 0th, 4th, and 8th weeks.

Interventions

OTHERPelvic Floor Muscle Training and Abdominal Training

Pelvic Floor Muscle Training + Abdominal Training program was used in the study. The follow-up measurements of the PFMT+AT group were obtained in the 0th, 4th, and 8th weeks.

OTHERPelvic Floor Muscle Training

Pelvic Floor Muscle Training program was used in the study. The follow-up measurements of the PFMT group were obtained in the 0th, 4th, and 8th weeks.

Sponsors

Trakya University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 49 Years
Healthy volunteers
No

Inclusion criteria

* 18-49 years * Meet the diagnosis of simple female stress urinary incontinence (Degree 0 or 1) * Volunteer to participate the study

Exclusion criteria

* BMI ≥30 * Hysterectomy, urinary incontinence or pelvic floor operations * Chronic health problem (cardiovascular, cerebral, diabetes, liver, kidney, psychiatric disease, etc.) * Urge urinary incontinence, mixed urinary incontinence, overflow urinary incontinence * SUI Degree ≥2 * Symptomatic urinary tract infection * During pregnancy or lactation period

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline pelvic floor muscle strength at 8 weeks0th, 4th, and 8th weeks.Pelvic floor muscle strength was measured using a perineometry device

Secondary

MeasureTime frameDescription
Change from baseline UDI-6 score at 8 weeks0th, 4th, and 8th weeks.Urinary symptoms were measured using the Urinary Distress Inventory (UDI-6)
Change from baseline IIQ-7 score at 8 weeks0th, 4th, and 8th weeksUrinary symptoms were measured using the Incontinence Impact Questionnaire (IIQ-7),

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026